FULLER H B CO 8-K

What Happened

• On June 25, 2026, H.B. Fuller Company announced a recommended cash offer through its subsidiary H.B. Fuller Medical Adhesive Technologies Inc. (Bidco) to acquire Advanced Medical Solutions Group plc (AMS) for 285 pence in cash per AMS share. The offer will be implemented by a court‑sanctioned scheme of arrangement under the UK Companies Act (or, with consent, by a takeover offer).
• The companies signed a Co-operation Agreement and Bidco secured bridge financing agreements with Goldman Sachs Bank USA as Administrative Agent to fund the transaction and related costs. The transaction is expected to close, subject to conditions and approvals, by the end of 2026, with a long‑stop date of June 25, 2027.

Key Details

• Offer price: 285 pence cash per AMS share.
• Financing: Secured bridge facility up to $2,086,713,188 and Unsecured bridge facility up to $917,000,000, arranged by Goldman Sachs Bank USA.
• Timing & approvals: Scheme requires AMS shareholder approval (majority by number and at least 75% by value), High Court sanction, regulatory approvals; expected completion by end of 2026; long‑stop date June 25, 2027.
• Board support and commitments: AMS directors holding 745,766 shares (≈0.34%) delivered irrevocable undertakings to vote in favor of the scheme; Bidco and AMS agreed to cooperate on approvals, filings and employee equity plan treatment.

Why It Matters

• The announcement is material because it sets the agreed acquisition price and shows H.B. Fuller has arranged near‑term bridge financing large enough to fund the cash consideration and related costs. That affects H.B. Fuller’s near‑term financing profile and potential leverage until permanent financing is arranged or the deal closes.
• The transaction remains subject to shareholder and regulatory approvals and standard closing conditions; investors should watch for the formal Scheme Document, regulatory clearances, any financing draws, and the timing of closing or any alternative takeover offer.